gliogen TEMOZOLOMIDE

Introduction to gliogen

Gliogen is a medication primarily used to treat certain aggressive brain tumors, such as glioblastoma multiforme and anaplastic astrocytoma. Gliogen is available in tablet form and is designed to interfere with the DNA of cancer cells, preventing their growth and division.

Composition of gliogen

Gliogen contains the active ingredient Temozolomide, which belongs to a class of drugs known as alkylating agents. These agents work by adding an alkyl group to the DNA of cancer cells, causing damage and stopping their multiplication.

Uses of gliogen

• Treatment of glioblastoma multiforme
• Treatment of anaplastic astrocytoma

Side effects of gliogen

• Common side effects: nausea, vomiting, fatigue
• Serious side effects: severe bone marrow suppression, increased risk of infection

Precautions of gliogen

Patients should be aware that gliogen can lower blood cell counts, increasing the risk of infection. It is not recommended for use during pregnancy due to potential harm to the unborn baby. Patients with severe bone marrow suppression should avoid using this medication.

How to Take gliogen

Gliogen is typically taken orally on an empty stomach, either one hour before or two hours after a meal. The usual starting dose for adults is 150 mg/m² once daily for five days in a 28-day cycle. Always follow your doctor's advice for the correct dosage and administration method.

Conclusion of gliogen

Gliogen, containing the active ingredient Temozolomide, is a therapeutic agent used in the treatment of aggressive brain tumors. It is manufactured to interfere with cancer cell DNA, preventing their growth. Key highlights include its use in treating glioblastoma multiforme and anaplastic astrocytoma, with common side effects such as nausea and fatigue. Always consult your healthcare provider for personalized advice on using gliogen.